MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs
As featured on
Recent milestones include strategic collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for